Skip to content Skip to navigation

New Blog Post:

First-in-Human Results for GB-0669: Durable Neutralization from an AI-Designed Antibody

Announcement:

Generate:Biomedicines to Present Phase 1 Results for AI-Engineered GB-0895 in Asthma

Flagship Pioneering
  • Generative Biology™
  • Platform
  • Pipeline
  • About Us
  • Careers
  • Media Center
  • Contact
  • LinkedIn
  • X
  • YouTube
Presentations & Publications

ERS 2025: ePoster

09.28.2025
Download as PDF
  • Generative Biology™
  • Platform
  • Pipeline
  • About Us
  • Careers
  • Media Center
  • Contact
Now we can.

Generate:Biomedicines

101 South Street, Suite 900
Somerville, MA 02143

United States

© 2025 Generate:Biomedicines
  • LinkedIn
  • X
  • YouTube
Privacy Policy Terms of Use Cookie Settings